BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6478412)

  • 1. Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature.
    Young JA; Newcomer LN; Keller AM
    Cancer; 1984 Oct; 54(8):1731-3. PubMed ID: 6478412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transient bone marrow inhibition caused by aminoglutethimide].
    Tel W; van Lijf JH; ten Napel CH
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):126-8. PubMed ID: 2922066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
    Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
    Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglutethimide-induced leukopenia: a case report and review of the literature.
    Gez E; Sulkes A
    Oncology; 1984; 41(6):399-402. PubMed ID: 6504495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible thrombocytopenia following aminoglutethimide.
    Kissin MW; Kark AE
    Cancer Treat Rep; 1983 Sep; 67(9):849. PubMed ID: 6883365
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglutethimide-induced hematologic toxicity: worldwide experience.
    Messeih AA; Lipton A; Santen RJ; Harvey HA; Boucher AE; Murray R; Ragaz J; Buzdar AU; Nagel GA; Henderson IC
    Cancer Treat Rep; 1985 Sep; 69(9):1003-4. PubMed ID: 4028032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
    Harris AL; Hughes G; Barrett AJ; Abusrewil S; Dowsett M; Smith IE
    Br J Cancer; 1986 Jul; 54(1):119-22. PubMed ID: 3730249
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglutethimide-induced myelosuppression.
    van der Heijden JT; Splinter TA
    Breast Cancer Res Treat; 1986; 7(3):211-2. PubMed ID: 3779118
    [No Abstract]   [Full Text] [Related]  

  • 9. Aminoglutethimide-induced hyperkalaemia.
    Davies JP; Bentley P; Ghose RR
    Br J Clin Pract; 1989 Jul; 43(7):263-4. PubMed ID: 2597612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Panmyelopathy induced by aminoglutethimide. Report of a clinical case].
    Wander HE
    Onkologie; 1984 Dec; 7(6):367-9. PubMed ID: 6396564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.
    Vincent MD; Clink HM; Coombes RC; Smith IE; Kandler R; Powles TJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):105-6. PubMed ID: 2990631
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic breast cancer with aminoglutethimide.
    Asbury RF; Bakemeier RF; Fölsch E; McCune CS; Savlov E; Bennett JM
    Cancer; 1981 Apr; 47(8):1954-8. PubMed ID: 7226090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis induced by aminoglutethimide.
    Mathijs R; Coolen D; Hermans-Debaive C
    Acta Clin Belg; 1988; 43(2):146-8. PubMed ID: 2840788
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglutethimide induced agranulocytosis in breast cancer.
    Caldwell G; Bradbury A; Toft AD
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):970-1. PubMed ID: 3929986
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukopenia associated with aminoglutethimide therapy: a case report.
    Austerlitz J
    Cancer Treat Rep; 1982 Oct; 66(10):1879. PubMed ID: 7127328
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglutethimide treatment in advanced breast cancer: an efficient therapy as a late endocrine alternative in a sequential therapeutic approach.
    Kvinnsland S; Dahl O
    Breast Cancer Res Treat; 1983; 3(1):73-6. PubMed ID: 6871483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.